fosbretabulin: Clinical Trials

2 trials of fosbretabulin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated, 1 withdrawn. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Terminated 1, Withdrawn 1
Phase 21Terminated 1

Follow fosbretabulin: new trials by email Literature Review of fosbretabulin trials Research Report on fosbretabulin

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer
Fosbretabulin + paclitaxel + carboplatin, Placebo + paclitaxel + carboplatin - Anaplastic Thyroid Cancer
Phase 3WithdrawnMateon Therapeutics2015-03-012014-05-01
Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer
CA4P, paclitaxel, carboplatin - Anaplastic Thyroid Cancer
Phase 2 / Phase 3TerminatedMateon Therapeutics802007-08-012014-06-09

Conditions studied

Thyroid Carcinoma, Anaplastic (2)  ·  Thyroid Neoplasms (2)  ·  Head and Neck Neoplasms (1)

Sponsors

Mateon Therapeutics (2)

Countries

Belarus (1)  ·  Bulgaria (1)  ·  Egypt (1)  ·  India (1)  ·  Israel (1)  ·  Italy (1)  ·  Poland (1)  ·  Romania (1)  ·  Russia (1)  ·  Ukraine (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Julie A Sosa, MD (1)  ·  Julie A. Sosa, MD, FACS (1)  ·  Lisa Licitra, MD (1)  ·  Marcia Brose, MD, PhD (1)

Results publications

PMID 37816266